Tafazzin (TAZ) Peptide
-
- Target See all TAZ products
- TAZ (Tafazzin (TAZ))
- Origin
- Human, Mouse, Rat
-
Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Characteristics
- The peptide is used to block Anti-TAZ Antibody reactivity.
-
-
- Application Notes
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Storage
- -20 °C
- Storage Comment
- Shipped at 4°C. Store at -20°C for one year.
- Expiry Date
- 12 months
-
- Target
- TAZ (Tafazzin (TAZ))
- Synonyms
- wu:fb39f12 Peptide, zgc:91803 Peptide, MGC54019 Peptide, TAZ Peptide, taz Peptide, GB11956 Peptide, Afu2g13960 Peptide, BTHS Peptide, CMD3A Peptide, EFE Peptide, EFE2 Peptide, G4.5 Peptide, LVNCX Peptide, Taz1 Peptide, 5031411C02Rik Peptide, 9130012G04Rik Peptide, AW107266 Peptide, AW552613 Peptide, tafazzin Peptide, tafazzin L homeolog Peptide, tafazzin homolog Peptide, TAZ Peptide, taz Peptide, taz.L Peptide, LOC550948 Peptide, AFUA_2G13960 Peptide, AOR_1_318014 Peptide, Tsp_06712 Peptide, Taz Peptide
- Background
- EFE2, G4.5, Tafazzin, Protein G4.5
- Gene ID
- 6901
- UniProt
- Q16635
-